Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_assertion type Assertion NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_head.
- NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_assertion description "[MLL (ALL1, Htrx, HRX), which is located on chromosome band 11q23, frequently is rearranged in patients with therapy-related acute myeloid leukemia who previously were treated with DNA topoisomerase II inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_provenance.
- NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_assertion evidence source_evidence_literature NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_provenance.
- NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_assertion SIO_000772 10339604 NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_provenance.
- NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_assertion wasDerivedFrom befree-2016 NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_provenance.
- NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_assertion wasGeneratedBy ECO_0000203 NP253352.RA5UMIgkGBR1zFF4uN6mbHfqp6M2SHohK0mHQ6CuDb6z0130_provenance.